| Brady Asa Fleshman, MD | |
|
7115 E Saint Charles Rd, Columbia, MO 65202-0196 | |
| (573) 884-6851 | |
| (573) 884-0293 |
| Full Name | Brady Asa Fleshman |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 7115 E Saint Charles Rd, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790134518 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2018007357 (Missouri) | Secondary |
| 207QS0010X | Family Medicine - Sports Medicine | 2018007357 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Missouri Health Care | Columbia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Curators Of The University Of Missouri | 4486759560 | 959 |
News Archive
Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
22nd Century Limited, LLC is pleased to announce that it is continuing development of a very low nicotine cigarette for use in smoking cessation. Clinical trial results demonstrate that these cigarettes, also referred to as ‘nicotine-free' and ‘denicotinized,' may be more effective for quitting than FDA-approved therapies.
The federal government released some very reliable estimates of how many people had health insurance in the first three months of 2014.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
› Verified 4 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
22nd Century Limited, LLC is pleased to announce that it is continuing development of a very low nicotine cigarette for use in smoking cessation. Clinical trial results demonstrate that these cigarettes, also referred to as ‘nicotine-free' and ‘denicotinized,' may be more effective for quitting than FDA-approved therapies.
The federal government released some very reliable estimates of how many people had health insurance in the first three months of 2014.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brady Asa Fleshman, MD Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Brady Asa Fleshman, MD 7115 E Saint Charles Rd, Columbia, MO 65202-0196 Ph: (573) 884-6851 |
News Archive
Lorraine Stone was born with heart disease. When just three days old she was the youngest person in the world at that time to survive a heart by-pass operation. Since then she has had five major heart operations. Miraculously, at the age 29, she is expecting to give birth to her second child in July.
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
22nd Century Limited, LLC is pleased to announce that it is continuing development of a very low nicotine cigarette for use in smoking cessation. Clinical trial results demonstrate that these cigarettes, also referred to as ‘nicotine-free' and ‘denicotinized,' may be more effective for quitting than FDA-approved therapies.
The federal government released some very reliable estimates of how many people had health insurance in the first three months of 2014.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
› Verified 4 days ago
Nicholas Michael Lefevre, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 551 E Southampton Dr, Columbia, MO 65201 Phone: 573-884-7733 Fax: 573-882-6228 | |
Richelle J Koopman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2325 Smiley Ln, Columbia, MO 65202 Phone: 573-884-8980 Fax: 573-884-0040 | |
Susan Z. John, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 909 Hitt St, Columbia, MO 65211 Phone: 573-882-7481 Fax: 573-882-5370 | |
Dr. Christopher Joseph Sporleder, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Dr. Christopher D. Farmer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 S Keene St, Columbia, MO 65201 Phone: 573-443-2402 Fax: 573-443-0574 | |
David D Cravens, MD, MSPH, CMD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: One Hospital Drive, Columbia, MO 65201 Phone: 573-884-7733 Fax: 573-884-5559 | |
Dr. Shannon Rhea Sitzmann, DNP, APRN, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2900 Trimble Rd Ste 107, Columbia, MO 65201 Phone: 573-818-3067 |